@article{42d39fb0ce58497881724e1142971fda,
title = "First in class (S,E)-11-[2-(arylmethylene)hydrazono]-PBD analogs as selective CB2 modulators targeting neurodegenerative disorders",
keywords = "Cannabinoid receptors CB1/CB2, Central nervous system (CNS), Neurodegenerative diseases, Neuroinflammation, Pyrrolobenzodiazepines",
author = "David Mingle and Meirambek Ospanov and Radwan, \{Mohamed O.\} and Nicole Ashpole and Masami Otsuka and Ross, \{Samir A.\} and Walker, \{Larry A.\} and Shilabin, \{Abbas G.\} and Ibrahim, \{Mohamed A.\}",
note = "Publisher Copyright: {\textcopyright} 2020, Springer Science+Business Media, LLC, part of Springer Nature.",
year = "2021",
month = jan,
doi = "10.1007/s00044-020-02640-2",
language = "English",
volume = "30",
pages = "98--108",
journal = "Medicinal Chemistry Research",
issn = "1054-2523",
number = "1",
}